Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q1 EPS of ($0.17), $0.01 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.